Showing results (151-160 of 180) with videos related to
Sort By:
Pageof 18
American Journal of Physiology. Cell Physiology|September 4, 2009
Pancreas-specific aquaporin 12 null mice showed increased susceptibility to caerulein-induced acute pancreatitisEriko Ohta, Tomohiro Itoh, Tomomi Nemoto, et al.Internal Medicine (Tokyo, Japan)|November 3, 2009
Successful use of single-dose rituximab for the maintenance of remission in a patient with steroid-resistant nephrotic syndromeNoritomo Kurosu, Hidekazu Sugiura, Chihiro Iwasaki, et al.Nephron. Clinical Practice|August 10, 2010
Effect of single-dose rituximab on primary glomerular diseasesHidekazu Sugiura, Takashi Takei, Mitsuyo Itabashi, et al.American Heart Journal Plus : Cardiology Research and Practice|April 24, 2026
Mid-term prognosis and risk stratification in patients with post-operative pulmonary hypertension: Insights from the Japanese Association of Congenital Heart Disease Registry (JACPHR)Naofumi F Sumitomo, Taku Ishii, Keiko Uchida, et al.Nihon Jinzo Gakkai Shi|September 5, 2008
[Effects of steroid therapy on membranous nephropathy]Takashi Takei, Asuka Aoki, Aya Eguchi, et al.Internal Medicine (Tokyo, Japan)|April 3, 2012
Rituximab treatment for adult patients with focal segmental glomerulosclerosisAyami Ochi, Takashi Takei, Kayu Nakayama, et al.The Journal of Veterinary Medical Science|September 6, 2008
Retrospective diagnosis of feline GM2 gangliosidosis variant 0 (Sandhoff-like disease) in Japan: possible spread of the mutant allele in the Japanese domestic cat populationOsamu Yamato, Daisuke Hayashi, Hiroyuki Satoh, et al.Internal Medicine (Tokyo, Japan)|October 9, 2010
Risedronate therapy for the prevention of steroid-induced osteoporosis in patients with minimal-change nephrotic syndromeTakashi Takei, Mitsuyo Itabashi, Misao Tsukada, et al.Pathology International|September 12, 2019
Fate of full-house immunofluorescence staining in renal allograft: A case reportAnri Sawada, Kohei Unagami, Shigeru Horita, et al.The American Journal of Cardiology|August 8, 2025
Pharmacological Treatment Practices for Patients With Congenital Heart Disease and Pulmonary Hypertension in Japan: Insights from the Japanese Association of Congenital Heart Disease Registry (JACPHR)Taku Ishii, Keiko Uchida, Susumu Hosokawa, et al.Pageof 18